Royalty Pharma PLC
(NAS:RPRX)
$
26.6
0.31 (1.18%)
Market Cap: 11.82 Bil
Enterprise Value: 17.66 Bil
PE Ratio: 10.43
PB Ratio: 1.73
GF Score: 79/100 Royalty Pharma PLC at Goldman Sachs Healthcare Conference Transcript
Jun 13, 2023 / 09:00PM GMT
Release Date Price:
$32.39
(-1.28%)
Chris Shibutani
Goldman Sachs Group, Inc., Research Division - Research Analyst
Thank you very much for joining us this afternoon. My name is Chris Shibutani, member of the Goldman Sachs research team. We are thrilled to have Royalty Pharma present with us once again. Today, we have Terry Coyne, back for a repeat performance, you were with me last year also, and it looks like you brought a friend this time. So you have Christopher Hite, who is the Vice Chair. And I see -- is Marshall running around or did he hide from me this year?
Terrance Coyne
Royalty Pharma plc - Executive VP & CFO
He is hiding.
Chris Shibutani
Goldman Sachs Group, Inc., Research Division - Research Analyst
He is back at home, doing deals.
Questions & Answers
Chris Shibutani
Goldman Sachs Group, Inc., Research Division - Research Analyst
Okay. Well, that's perfect. So terrific. I think you're probably, to a certain extent, familiar to folks. But I always find that these are
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot